NASDAQ:OFIX Orthofix Medical (OFIX) Stock Price, News & Analysis → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free OFIX Stock Alerts $14.76 -0.34 (-2.25%) (As of 11:33 AM ET) Add Compare Share Share Today's Range$14.73▼$15.0850-Day Range$12.99▼$15.3752-Week Range$9.57▼$21.60Volume59,215 shsAverage Volume394,472 shsMarket Capitalization$553.94 millionP/E RatioN/ADividend YieldN/APrice Target$18.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Orthofix Medical alerts: Email Address Orthofix Medical MarketRank™ Stock AnalysisAnalyst RatingHold2.40 Rating ScoreUpside/Downside22.0% Upside$18.00 Price TargetShort InterestBearish10.79% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.39Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.43) to ($0.37) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.52 out of 5 starsMedical Sector871st out of 921 stocksSurgical & Medical Instruments Industry97th out of 100 stocks 2.2 Analyst's Opinion Consensus RatingOrthofix Medical has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageOrthofix Medical has only been the subject of 3 research reports in the past 90 days.Read more about Orthofix Medical's stock forecast and price target. Previous Next 0.0 Short Interest Percentage of Shares Shorted10.79% of the outstanding shares of Orthofix Medical have been sold short.Short Interest Ratio / Days to CoverOrthofix Medical has a short interest ratio ("days to cover") of 11, which indicates bearish sentiment.Change versus previous monthShort interest in Orthofix Medical has recently increased by 7.14%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldOrthofix Medical does not currently pay a dividend.Dividend GrowthOrthofix Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OFIX. Previous Next 1.3 News and Social Media Coverage News SentimentOrthofix Medical has a news sentiment score of 0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Orthofix Medical this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for OFIX on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Orthofix Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.70% of the stock of Orthofix Medical is held by insiders.Percentage Held by Institutions89.76% of the stock of Orthofix Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Orthofix Medical's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Orthofix Medical are expected to grow in the coming year, from ($1.43) to ($0.37) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Orthofix Medical is -4.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Orthofix Medical is -4.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOrthofix Medical has a P/B Ratio of 0.92. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Orthofix Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Allegiance GoldDoes this make you sick?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit About Orthofix Medical Stock (NASDAQ:OFIX)Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.Read More OFIX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OFIX Stock News HeadlinesMay 17, 2024 | americanbankingnews.comCritical Analysis: Valeritas (OTCMKTS:VLRXQ) & Orthofix Medical (NASDAQ:OFIX)May 16, 2024 | businesswire.comOrthofix Wins “Best Patient Experience Solution” Award in 2024 MedTech Breakthrough Awards ProgramMay 12, 2024 | americanbankingnews.comBrokerages Set Orthofix Medical Inc. (NASDAQ:OFIX) Price Target at $18.00May 12, 2024 | americanbankingnews.comOrthofix Medical (NASDAQ:OFIX) Upgraded by Roth Mkm to "Buy"May 9, 2024 | msn.comRoth MKM Upgrades Orthofix Medical (OFIX)May 9, 2024 | msn.comOrthofix gets FDA clearance for Rodeo Telescopic NailMay 9, 2024 | finance.yahoo.comOrthofix Announces FDA 510(k) Clearance for the Rodeo Telescopic NailMay 8, 2024 | msn.comRoth MKM ups Orthofix to buy, cites improving fundamentalsMay 8, 2024 | finance.yahoo.comOrthofix Medical Inc. (NASDAQ:OFIX) Q1 2024 Earnings Call TranscriptMay 8, 2024 | finance.yahoo.comOrthofix Medical Inc (OFIX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...May 7, 2024 | investorplace.comOFIX Stock Earnings: Orthofix Medical Meets EPS, Beats Revenue for Q1 2024May 7, 2024 | markets.businessinsider.comOrthofix Medical Inc. Q1 Loss decreases, but misses estimatesMay 7, 2024 | finance.yahoo.comOrthofix Reports First Quarter 2024 ResultsMay 7, 2024 | finance.yahoo.comOrthofix Medical Inc. (OFIX) Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Net Loss WideningMay 7, 2024 | seekingalpha.comOrthofix Medical Inc. 2024 Q1 - Results - Earnings Call PresentationApril 26, 2024 | msn.comMarriott Vacations, Carrols Restaurant Group, and More Stocks See Action From Activist InvestorsApril 23, 2024 | businesswire.comOrthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024April 22, 2024 | finance.yahoo.comSacroiliac Joint Fusion Market To Reach USD 4,106.7 Billion By 2032 | DataHorizzon ResearchApril 22, 2024 | markets.businessinsider.comStryker’s Resilience Amidst Competitive Pressures Reinforces Buy RatingApril 19, 2024 | markets.businessinsider.comOrthofix (OFIX) Gets a Hold from JMP SecuritiesApril 16, 2024 | finance.yahoo.comOrthofix Names Andres Cedron as New Chief Legal OfficerApril 1, 2024 | uk.finance.yahoo.comMesenchymal Stem Cells (MSCs) Advancements & Global Market Potential Highlighted in Comprehensive Strategic ReportMarch 28, 2024 | tmcnet.comBRIJ Medical Bolsters Leadership Team: John Grotting Named Chairman, Bob Zollars and Jim Hinrichs Join BoardMarch 7, 2024 | finance.yahoo.comOrthofix Medical Inc (OFIX) Reports Significant Sales Growth and Improved EBITDA in Q4 and Full ...March 6, 2024 | ca.finance.yahoo.comOrthofix Medical Inc. (OM2.F)See More Headlines Receive OFIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Orthofix Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/05/2024Today5/21/2024Next Earnings (Estimated)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:OFIX CUSIPN6748L10 CIK884624 Webwww.orthofix.com Phone(214) 937-2000Fax599 9 461 6978Employees1,634Year Founded1980Price Target and Rating Average Stock Price Target$18.00 High Stock Price Target$20.00 Low Stock Price Target$16.00 Potential Upside/Downside+19.2%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($3.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-151,400,000.00 Net Margins-16.64% Pretax Margin-16.25% Return on Equity-14.24% Return on Assets-9.49% Debt Debt-to-Equity Ratio0.23 Current Ratio2.65 Quick Ratio1.19 Sales & Book Value Annual Sales$760.05 million Price / Sales0.75 Cash FlowN/A Price / Cash FlowN/A Book Value$16.11 per share Price / Book0.94Miscellaneous Outstanding Shares37,529,000Free Float35,765,000Market Cap$566.69 million OptionableOptionable Beta1.06 Social Links 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMs. Kimberley A. Elting (Age 59)President of Global Orthopedics Comp: $766.67kMs. Julie B. Andrews (Age 53)Chief Financial Officer Mr. Roberto DonadelloSenior Vice President of Global OperationsMr. Dan E. YarbroughVice President of Investor RelationsMs. Jill MasonInterim Chief Ethics & Compliance Officer and VP of Corporate CounselMr. Ehab M. Esmail (Age 52)Senior Vice President of Global Quality, Regulatory & Clinical Affairs Mr. Tyler P. Lipschultz (Age 57)President of Global Biologics Dr. Beau Standish P.Eng. (Age 43)Ph.D., President of Global Enabling Technologies Mr. Geoffrey C. GillespieVP & Corporate ControllerMore ExecutivesKey CompetitorsSurmodicsNASDAQ:SRDXAngioDynamicsNASDAQ:ANGOIntersect ENTNASDAQ:XENTAccurayNASDAQ:ARAYAtriCureNASDAQ:ATRCView All CompetitorsInsiders & InstitutionsJacobs Levy Equity Management Inc.Sold 255,053 shares on 5/16/2024Ownership: 1.046%California State Teachers Retirement SystemSold 5,255 shares on 5/16/2024Ownership: 0.089%Gamco Investors INC. ET ALBought 25,900 shares on 5/15/2024Ownership: 0.399%Gabelli Funds LLCBought 6,500 shares on 5/15/2024Ownership: 0.390%Price T Rowe Associates Inc. MDBought 1,236 shares on 5/15/2024Ownership: 0.088%View All Insider TransactionsView All Institutional Transactions OFIX Stock Analysis - Frequently Asked Questions Should I buy or sell Orthofix Medical stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" OFIX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OFIX, but not buy additional shares or sell existing shares. View OFIX analyst ratings or view top-rated stocks. What is Orthofix Medical's stock price target for 2024? 5 equities research analysts have issued twelve-month price objectives for Orthofix Medical's stock. Their OFIX share price targets range from $16.00 to $20.00. On average, they predict the company's share price to reach $18.00 in the next year. This suggests a possible upside of 22.0% from the stock's current price. View analysts price targets for OFIX or view top-rated stocks among Wall Street analysts. How have OFIX shares performed in 2024? Orthofix Medical's stock was trading at $13.48 on January 1st, 2024. Since then, OFIX shares have increased by 9.5% and is now trading at $14.76. View the best growth stocks for 2024 here. When is Orthofix Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024. View our OFIX earnings forecast. How were Orthofix Medical's earnings last quarter? Orthofix Medical Inc. (NASDAQ:OFIX) issued its quarterly earnings results on Tuesday, March, 5th. The medical device company reported ($0.59) earnings per share for the quarter, topping analysts' consensus estimates of ($0.60) by $0.01. The medical device company earned $200.42 million during the quarter. Orthofix Medical had a negative trailing twelve-month return on equity of 14.24% and a negative net margin of 16.64%. What ETFs hold Orthofix Medical's stock? ETFs with the largest weight of Orthofix Medical (NASDAQ:OFIX) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE) and Invesco Nasdaq Future Gen 200 ETF (QQQS).iShares U.S. Medical Devices ETF (IHI). What guidance has Orthofix Medical issued on next quarter's earnings? Orthofix Medical updated its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $790.0 million-$795.0 million, compared to the consensus revenue estimate of $790.8 million. What is Brad Mason's approval rating as Orthofix Medical's CEO? 32 employees have rated Orthofix Medical Chief Executive Officer Brad Mason on Glassdoor.com. Brad Mason has an approval rating of 73% among the company's employees. What other stocks do shareholders of Orthofix Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Edwards Lifesciences (EW), Gilead Sciences (GILD), Biogen (BIIB), Pfizer (PFE), Exxon Mobil (XOM), Advanced Micro Devices (AMD), bluebird bio (BLUE) and Esperion Therapeutics (ESPR). Who are Orthofix Medical's major shareholders? Orthofix Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (5.37%), Jacobs Levy Equity Management Inc. (1.05%), Jupiter Asset Management Ltd. (0.69%), Russell Investments Group Ltd. (0.59%), Mutual of America Capital Management LLC (0.47%) and Gamco Investors INC. ET AL (0.40%). Insiders that own company stock include Catherine M Burzik, James F Hinrichs, Jon Carl Serbousek, Kevin J Kenny, Kimberley A Elting, Michael E Paolucci, Rice Doug and Shweta Maniar. View institutional ownership trends. How do I buy shares of Orthofix Medical? Shares of OFIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:OFIX) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersNext President (Not Trump. Not Biden.)The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Crypto for AIWeiss RatingsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersBill Gates is all about this tiny $2 stockTimothy SykesThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orthofix Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.